The search for safe strategies "according to Nature" for the neuro-immune well-being of the child
Paediatric neuroinflammatory disorders can affect the peripheral and central nervous systems, as well as the immune system. They are a response to biological, environmental and pathological factors. It can be associated with various conditions, including: neurodevelopmental disorders (e.g. autism spectrum disorder), chronic pain (e.g. joint or abdominal) , skin conditions (e.g. eczematous dermatitis), respiratory conditions (recurrent respiratory infections). Uncontrolled inflammation can affect the child’s physiological growth and cerebral maturation processes. It can also have an impact on their long-term neurological health.
ALIAmides, lipid compounds that regulate endogenous inflammatory response, are an innovative strategy for modulating neuroinflammation in children. Published research has shown that these molecules can help to reduce the anomalous activation of non-neuronal cells.
Mastocyte hyperactivation, resulting from contact with the allergen, determines its degranulation and characteristic symptoms of allergies.
Our Paediatric Line was developed using a cutting-edge scientific approach. Special attention was placed on ensuring the safety and effectiveness of the formulations. The aim is to offer targeted solutions for controlling paediatric neuroinflammatory disorders, in order to promote their health and favour their healthy neurological development.